These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 26368010

  • 1. Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes.
    Sirikunalai P, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, Traisrisilp K, Tongsong T.
    J Obstet Gynaecol; 2016; 36(2):178-82. PubMed ID: 26368010
    [Abstract] [Full Text] [Related]

  • 2. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K.
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [Abstract] [Full Text] [Related]

  • 3. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH.
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [Abstract] [Full Text] [Related]

  • 4. Maternal first trimester serum levels of free-beta human chorionic gonadotrophin and male genital anomalies.
    Schneuer FJ, Bower C, Holland AJ, Tasevski V, Jamieson SE, Barker A, Lee L, Majzoub JA, Nassar N.
    Hum Reprod; 2016 Aug; 31(8):1895-903. PubMed ID: 27496947
    [Abstract] [Full Text] [Related]

  • 5. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V, Chernev T, Vragaleva S, Slŭncheva B, Mikhaĭlova E, Kremenski I, Simeonov E.
    Akush Ginekol (Sofiia); 2002 Aug; 41(6):3-12. PubMed ID: 12577497
    [Abstract] [Full Text] [Related]

  • 6. [Relationship of adverse pregnancy outcomes and a high risk serum screen for Down syndrome in the second trimester].
    Hu XY, Bian XM, Jiang YL, Liu SY.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):427-30. PubMed ID: 22932108
    [Abstract] [Full Text] [Related]

  • 7. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
    Chen Y, Dai X, Wu B, Jiang C, Yin Y.
    BMC Womens Health; 2024 Jun 04; 24(1):323. PubMed ID: 38835013
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
    Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME.
    Am J Obstet Gynecol; 2004 Oct 04; 191(4):1446-51. PubMed ID: 15507981
    [Abstract] [Full Text] [Related]

  • 10. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ, Dickinson JE, O'Leary P, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R.
    Aust N Z J Obstet Gynaecol; 2008 Dec 04; 48(6):529-35. PubMed ID: 19133038
    [Abstract] [Full Text] [Related]

  • 11. Elevated maternal serum-free β-human chorionic gonadotropin (β-hCG) and reduced risk of spontaneous preterm delivery.
    Soni S, Krantz DA, Blitz MJ, Vohra N, Rochelson B.
    J Matern Fetal Neonatal Med; 2019 Oct 04; 32(19):3191-3196. PubMed ID: 29642747
    [Abstract] [Full Text] [Related]

  • 12. The impact of assisted reproductive technology on the association between first-trimester pregnancy-associated plasma protein a and human chorionic gonadotropin and adverse pregnancy outcomes.
    Zhong Y, Bradshaw R, Stanley AP, Odibo AO.
    Am J Perinatol; 2011 May 04; 28(5):347-54. PubMed ID: 21082535
    [Abstract] [Full Text] [Related]

  • 13. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery.
    Morssink LP, Kornman LH, Hallahan TW, Kloosterman MD, Beekhuis JR, de Wolf BT, Mantingh A.
    Prenat Diagn; 1998 Feb 04; 18(2):147-52. PubMed ID: 9516016
    [Abstract] [Full Text] [Related]

  • 14. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.
    Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group.
    Am J Obstet Gynecol; 2004 Oct 04; 191(4):1452-8. PubMed ID: 15507982
    [Abstract] [Full Text] [Related]

  • 15. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
    Ranta JK, Raatikainen K, Romppanen J, Pulkki K, Heinonen S.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul 04; 157(1):48-52. PubMed ID: 21482016
    [Abstract] [Full Text] [Related]

  • 16. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
    Savvidou MD, Syngelaki A, Muhaisen M, Emelyanenko E, Nicolaides KH.
    BJOG; 2012 Mar 04; 119(4):410-6. PubMed ID: 22324916
    [Abstract] [Full Text] [Related]

  • 17. Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population.
    Hsieh TT, Hung TH, Hsu JJ, Shau WY, Su CW, Hsieh FJ.
    Obstet Gynecol; 1997 Jun 04; 89(6):937-40. PubMed ID: 9170469
    [Abstract] [Full Text] [Related]

  • 18. Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes.
    Settiyanan T, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, Traisrisilp K, Tongsong T.
    J Matern Fetal Neonatal Med; 2016 Jun 04; 29(13):2093-7. PubMed ID: 27480207
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.